Bronchiectasis: Advancing into the Future
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 187
Special Issue Editors
Interests: cystic fibrosis; bronchiectasis; NTM; sleep medicine; critical care
Special Issues, Collections and Topics in MDPI journals
Interests: cystic fibrosis; bronchiectasis; COPD; chronic cough
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
1. Introduction
Bronchiectasis presents one of the most clinically challenging and heterogeneous chronic airway diseases in contemporary pulmonary medicine. Once regarded primarily as an end-stage anatomic consequence of recurrent infection, bronchiectasis is now recognized as a dynamic syndrome—characterized by a perpetuating cycle of impaired mucociliary clearance, persistent airway inflammation, microbial dysbiosis, and recurrent exacerbations. Patients experience a substantial burden of symptoms, reduced quality of life, progressive loss of lung function, and frequent hospitalizations. Despite growing awareness, bronchiectasis remains underdiagnosed, variably evaluated, and inconsistently treated across clinical settings, reflecting both its complexity and the limitations of current evidence-based care pathways. Experienced clinicians frequently face uncertainty regarding how to determine the “right” intensity of therapy for a given patient phenotype—and how best to personalize care in the precision medicine era.
We invite submissions for this Special Issue, titled, “Bronchiectasis: Advancing into the Future”, to contribute to what we hope to be an enlightening collection of present-day and newly gained knowledge in this field.
2. Aim
This Special Issue aims to advance a modern, pragmatic, and scientifically grounded approach to bronchiectasis across its diverse etiologies and phenotypes. Ultimately, the goal of this collection is to equip clinicians with the tools necessary to recognize bronchiectasis earlier, define its underlying etiology more precisely, and deliver care that is both multidisciplinary and patient-centered leading to tangible benefits and improved outcomes.
3. Suggested Themes
In this Special Issue, original research articles and state-of-the-art reviews across the spectrum of bronchiectasis research are welcome. Suggested themes may include but are not limited to the following:
- Bronchiectasis Endotypes, Phenotypes
- CFTR-related disorder in Bronchiectasis
- Airway Microbiome
- Exercise and Functional Assessment
- Guidelines / Reviews
- Advanced Disease Management
- NTM
- Antimicrobial Strategies
- Disease Modifying Strategies
- Exacerbation Prediction models
- Biologics in Bronchiectasis
- Future Directions/Research Pipeline
- Complications Management
- Airway Clearance
Dr. Janice Wang
Dr. Patricia A. Walker
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-CF bronchiectasis
- NCFB
- airway microbiome
- non-tuberculous mycobacteria (NTM)
- biologics
- endotypes
- phenotypes
- novel therapeutics
- exacerbations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
